Merrimack to dissolve after recording $225M milestone; Cogent’s $225M placement
Plus, news about Larimar Therapeutics, Metagenomi, NextPoint Therapeutics, MeiraGTx, Codexis, Invitae, Immunome and BioXcel Therapeutics: Ipsen to pay $225M to Merrimack Pharmaceuticals: The milestone payout